$2.33
-0.01 (-0.43%)
Open$2.35
Previous Close$2.34
Day High$2.50
Day Low$2.29
52W High$12.37
52W Low$1.81
Volume—
Avg Volume134.5K
Market Cap19.21M
P/E Ratio—
EPS$-1.96
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+733.0% upside
Current
$2.33
$2.33
Target
$19.41
$19.41
$13.09
$19.41 avg
$19.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.99M | 1.89M | 22.16M |
| Net Income | -14,566,769 | -8,291,229 | 3.56M |
| Profit Margin | -487.1% | -462.7% | 16.1% |
| EBITDA | -15,599,774 | -9,372,492 | 4.85M |
| Free Cash Flow | — | — | 3.49M |
| Rev Growth | +58.1% | +58.1% | +9.7% |
| Debt/Equity | — | — | 0.13 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |